Oncotarget, 2017 · DOI: · Published: December 1, 2016
Astrocytes, a major type of brain cell, play important roles in maintaining a healthy brain environment. However, they can also trigger immune responses when exposed to inflammatory signals. MIF, a protein involved in inflammation, increases after spinal cord injury and is found near both microglia and astrocytes. This study suggests that blocking MIF's interaction with its receptor, CD74, could be a way to reduce inflammation in the central nervous system after injury.
MIF/CD74 interaction represents a potential therapeutic target for controlling CNS inflammation after spinal cord injury.
Development of drugs targeting the MIF/CD74 axis may help modulate the inflammatory response in astrocytes and improve outcomes after CNS injury.
Modulating the expression or activity of Ch25h and Pla2g2a could offer new approaches for controlling innate immune responses in astrocytes.